Cart
sales@molnova.com
N.41
CAS No. 357441-99-7
N.41( HIV inhibitor N.41 | Vif inhibitor N.41 )
Catalog No. M14228 CAS No. 357441-99-7
N.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameN.41
-
NoteResearch use only, not for human use.
-
Brief DescriptionN.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM).
-
DescriptionN.41 (HIV inhibitor N.41, Vif inhibitor N.41) is a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G (A3G) protein (IC50=2.2 uM); shows potent antiviral activity in A3G(+) but not in A3G(-) T cells with IC50 of 8.4 uM and TC50 of >100 uM against HIV-1Ba-L replication in peripheral blood mononuclear cells; inhibits the Vif-A3G interaction and increases cellular A3G levels and incorporation of A3G into virions, thereby attenuating virus infectivity in a Vif-dependent manner.
-
In Vitro——
-
In Vivo——
-
SynonymsHIV inhibitor N.41 | Vif inhibitor N.41
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number357441-99-7
-
Formula Weight254.289
-
Molecular FormulaC15H14N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC/C(NC1=CC=C(O)C=C1)=C/C(C2=CC=CN=C2)=O
-
Chemical Name3-((4-hydroxyphenyl)amino)-1-(pyridin-3-yl)but-2-en-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pery E, et al. J Biol Chem. 2015 Apr 17;290(16):10504-17.
molnova catalog
related products
-
NBD-557
A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction; inhibits the fusion between HIV-1NL4-3-luc pseudotyped virus expressing HIV-1HXB2 (X4-tropic) envelope and U87-T4-CXCR4 cells with IC50 of 9.7 uM.
-
Raltegravir potassiu...
A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.
-
DRB
DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM).
